NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Ovarian Cancer



Studies describe new findings in ovarian cancer research



October 6th, 2005

Investigators in the United States and Canada have published new ovarian cancer data.

Study 1: Scientists explored the relation between androgen receptor (AR) cytosine, adenine, guanine (CAG) repeats, and haplotypes and the risk of ovarian cancer.

According to a study from the United States, "Biological and epidemiologic evidence suggest that androgen or its receptor may play a role in ovarian cancer pathogenesis. The most notable genetic factor influencing AR activity is the functional CAG repeat, in which length is inversely proportional to its transactivational activity. Additional genetic variation due to single nucleotide polymorphisms in the AR...


Source: Women's Health Weekly (2005-10-06)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login